Today: 11 June 2026
PLS Group (ASX:PLS) share price near 52-week high as China lithium firms; holiday week puts Jan 30 report in focus
24 January 2026
1 min read

PLS Group (ASX:PLS) share price near 52-week high as China lithium firms; holiday week puts Jan 30 report in focus

Sydney, Jan 24, 2026, 16:55 (AEDT) — Market closed.

  • PLS closed Friday 0.8% higher at A$5.08, having briefly hit the peak of its 52-week range.
  • Monday’s ASX cash market closure for Australia Day pushes focus onto Tuesday and PLS’s quarterly update scheduled for later this week.

PLS Group Limited shares closed Friday at A$5.08, rising 0.79%, after hitting a session high of A$5.16 — the peak of their 52-week range — ahead of the weekend.

This is important now as lithium stocks track commodity moves rather than company updates, with PLS standing out as one of the ASX’s most liquid plays. The speed of its price jumps when lithium chemical prices rise in China makes that clear.

Next week kicks off with a break. The ASX cash market will be closed Monday for Australia Day, shifting the next trading day to Tuesday and trimming the window for investors to tweak positions ahead of month-end.

Battery-grade lithium carbonate—a key chemical for battery cathodes—climbed once more on Jan. 23. Prices hit an average of 171,000 yuan per metric ton, up 6,500 yuan from the previous trading day, according to Shanghai Metals Market data.

That environment often influences how miners price spodumene concentrate, the ore that PLS extracts lithium from. The connection isn’t exact, yet traders keep a sharp eye on it.

PLS runs the Pilgangoora hard-rock lithium mine in Western Australia and owns the Colina project in Brazil. It also has downstream operations via a joint venture in South Korea, according to a Reuters company profile.

The next company update is due Friday. PLS plans to release its December 2025 quarterly activities report on Jan. 30, with an investor webcast scheduled for 10 a.m. AEDT, according to an ASX announcement.

Investors want to see shipment volumes, unit costs, and realised pricing, plus any insight on how the recent surge in lithium chemicals is impacting sales. Cash flow and spending plans will also be under close scrutiny.

But the situation works both ways. Should China’s lithium price rally lose steam by month-end, or if the quarterly update disappoints, the stock’s recent climb toward the top of its one-year range could reverse sharply.

Trading picks back up Tuesday, with the market focused on whether lithium’s recent rally sticks through the long weekend. The next major event on the calendar is the quarterly report and webcast set for Jan. 30.

Stock Market Today

  • Helix Energy Solutions (HLX) Q1 Review: Hold Amid Scaling and Profitability Concerns
    June 11, 2026, 10:44 AM EDT. Helix Energy Solutions (HLX) stock rose 35.6% to $9.67, outperforming the S&P 500 by 28.7% over six months. Despite gains, analysts caution on HLX due to its small scale with $1.3 billion annual revenue and an 11.4% average gross margin over five years, signaling weak profitability and limited growth compared to peers. With insufficient forecasts to justify a forward price-to-sales ratio of 1.1x, the stock faces risks amid more attractive opportunities elsewhere. Investors are advised to hold off on HLX and consider higher-quality alternatives, particularly in software sectors showing rapid gains.

Latest articles

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 24.01.2026

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Next Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

Go toTop